Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Anosmia

fluorodeoxyglucose f18 has been researched along with Anosmia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Arnaldi, D; Barisione, E; Bauckneht, M; Benedetti, L; Biassoni, E; Chiola, S; D'amico, F; Donegani, MI; Gianmario, S; Lanfranchi, F; Mancini, R; Miceli, A; Morbelli, S; Nobili, F; Orso, B; Pardini, M1
Bregeon, F; Cammilleri, S; Dudouet, P; Guedj, E; Million, M; Raoult, D; Tissot-Dupont, H1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Anosmia

ArticleYear
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:6

    Topics: Anosmia; COVID-19; Fluorodeoxyglucose F18; Humans; Olfaction Disorders; Parkinson Disease; RNA, Viral; SARS-CoV-2; Smell

2022
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:2

    Topics: Anosmia; Brain; COVID-19; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pain; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals

2021